Tomotherapy Incorporated (MM) (NASDAQ:TTPY)
Historical Stock Chart
From Jun 2019 to Jun 2024
TomoTherapy Incorporated (NASDAQ: TTPY) today announced that management
will participate in two investment community conferences in early
January 2008.
Steve Hathaway, CFO, will present at the Needham & Company, LLC 10th
Annual Growth Conference on Tuesday, Jan. 8, 2008, at 4:00 p.m.
ET. The conference is taking place Jan. 8-11, 2008, at the New York
Palace Hotel in New York City.
On Thursday, Jan. 10, 2008, Dr. Fred Robertson, CEO, and Steve Hathaway
will present at the JPMorgan Healthcare Conference at 8:30 a.m. PT. The
conference is being held Jan. 7-10, 2008, at the Westin St. Francis in
San Francisco.
A live Webcast of both presentations will be available on the investor
relations page of TomoTherapy’s Web site at www.TomoTherapy.com.
For those who are unable to listen to the live presentation, an archive
of the Webcast will be available on the company’s
site for 30 days following the presentation.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the
TomoTherapy® Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company completed its initial public offering in May 2007
and its stock is traded on the NASDAQ Global Market under the symbol
TTPY. Effective Jan. 2, 2008, the company’s
symbol will change to TOMO. To learn more about TomoTherapy, please
visit our Web site at www.TomoTherapy.com.
©2007 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated.